Preparing for China · patient guide

Multidisciplinary team review in China: what to know

A multidisciplinary team review brings two or three relevant specialties together to discuss one complex case, so the patient is not left piecing together separate opinions. In China it can be arranged as a records-based review before travel, but the scope, fee and participants are agreed first, and the treating hospital still decides suitability, diagnosis and treatment.

Go to the practical guidance ↓
AI illustration: Two medical professionals and two adults in a consultation room reviewing documents at a table.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What a multidisciplinary review actually is

A multidisciplinary team review, sometimes called an MDT review or tumour board depending on the condition, is a structured discussion in which clinicians from more than one specialty consider the same set of records together. The point is not to collect more opinions for their own sake. It is to resolve questions that cross specialty boundaries: whether a finding on imaging changes the surgical plan, whether a pathology result fits the clinical picture, whether a medical treatment should come before or after an operation, or whether the diagnosis itself is uncertain.

For an overseas patient, the practical value is usually clarity before committing to travel. Separate appointments can produce separate opinions that never quite meet. A joint discussion can identify what is genuinely undecided, what further information would settle it, and which specialty should lead. That is a planning output, not a guarantee of treatment.

It helps to separate three things that are easy to blur. A free initial case review by our team is non-clinical: we check what diagnosis, records and main question you have, note what is missing and suggest a next step. A records-based specialist opinion is a licensed clinician's assessment of the material available. A hospital MDT is the treating institution's own internal discussion, which may happen after you are accepted as a patient. These are different stages with different authority.

Who takes part, and who decides the scope

The specialties invited depend entirely on the question. A spinal case might involve orthopaedic or neurosurgical spine expertise alongside radiology. A cancer question might involve surgery, medical oncology, radiation oncology and pathology. A rare or undiagnosed condition might need a different combination again. There is no standard panel that suits every patient, and a review that includes the wrong specialties wastes everyone's time.

This is why the scope should be agreed before the review happens. For a complex or cross-specialty case, ChinaSpecialistCare can arrange a review involving two or three relevant specialties, with the scope and fee agreed first. That agreement should state which specialties are expected to contribute, what records they will see, whether the discussion is written, spoken or both, and what the output will look like.

Ask directly who will read your file. Will the named specialties each provide a written contribution, or will one clinician summarise the group's view? Is a pathologist or radiologist reviewing the original slides and images, or only a report? Will you receive a document you can take to your local doctor? These questions matter more than the label attached to the meeting.

The hospital, not the coordinator, decides whether a case is suitable for its own MDT and what that discussion concludes. Our role is coordination and interpretation support, not clinical judgement.

The records that make a review useful

A review is only as good as the material in front of it. A discussion can stall not because the diagnosis is difficult but because an original is missing: a pathology report without the slides, imaging described in a letter but not supplied as images, or a medication list that stops well before the present. Before requesting a review, gather the source documents rather than summaries alone.

For imaging, ask whether the original files are needed or whether reports suffice for the question being asked. For pathology, ask whether slides or blocks should be sent for re-review, since a second look at the tissue can change the interpretation. For laboratory work, include the dates. For prior treatment, include operation notes, discharge summaries and the current medication list with doses. A short chronology written by you, in plain language, helps the clinicians see the sequence quickly.

You do not need to assemble a complete archive before making first contact. A brief summary of the diagnosis, the main question and what records exist is enough to start. We can then explain what to send and how to share it securely. Do not send passport numbers, card details or a full medical file through an initial enquiry form.

It is also fair to ask what happens if a key record cannot be obtained. A review may proceed with stated limitations, or the clinicians may say the question cannot be answered without a particular document. Either answer is more useful than silence.

What the opinion can and cannot settle

A records-based multidisciplinary review can clarify how specialists interpret your existing information. It can identify whether the diagnosis is secure, which treatment options are reasonable to discuss, what further tests the treating team would want, and where the genuine uncertainty lies. It can help you prepare better questions and decide whether travelling to China for assessment is worth pursuing.

It cannot confirm hospital acceptance, book an operation, or replace an in-person examination. Some decisions depend on physical findings, on tests that have not yet been done, or on the treating surgeon's own assessment of imaging and tissue. A review conducted while you are at home is a considered opinion on available evidence, not final procedural clearance. If a clinician tells you the question needs an examination first, that is a legitimate answer.

Be cautious with any review that promises a definite outcome, a specific surgical plan or a guarantee of treatment before anyone has examined you. Equally, do not assume a review is a formality. A well-scoped discussion can change the direction of a plan, including by concluding that the original question was the wrong one.

For conditions where the evidence base is thin, such as some rare diseases, the review may be most useful for mapping what is known, what is not, and which specialists should be involved next. That is a real output even when no single answer emerges.

How a review fits with travelling to China

Some patients use a review to decide whether to travel at all. Others have already decided and want the review to shape the visit: which department to attend first, which records to bring, which tests might be requested. Both are reasonable, and the review should be framed around your actual decision rather than around a standard package.

If travel is likely, ask how the review connects to a hospital appointment. Will the reviewing clinicians be involved in your care in China, or is the review a separate opinion? Will the hospital accept the review as part of its own assessment, or repeat the work? These are administrative questions with real consequences for time and cost, and the answers belong to the specific provider, not to a general rule.

Keep the review and the hospital's own assessment distinct in your mind. A review can tell you that a question is worth pursuing in China. It cannot tell you that a particular hospital will accept you, that a bed will be available, or that a named surgeon will take the case. Those decisions sit with the hospital.

If your symptoms worsen or become urgent, seek local medical care rather than waiting for an overseas review. A planned discussion is not an emergency route.

Costs, fees and what to confirm in writing

The fee for a multidisciplinary review is agreed before the review takes place, and it is separate from hospital medical charges. Hospital consultations, tests, treatment, medicines and rooms are paid to the hospital or the relevant provider. Our coordination fees are separate, and there is no credit, offset or transfer of a review fee into later treatment costs.

Because the scope varies with the specialties involved and the records reviewed, ask for a written statement of what the agreed fee covers. Does it include review of imaging and pathology, a written summary, a follow-up discussion, or interpretation support? What is not included? Rather than assuming a standard structure, ask this provider what its actual quote contains for your case.

It is also reasonable to ask what happens if the review cannot proceed because records are missing or the question falls outside the specialties available. A clear answer before payment is more useful than a refund policy discovered afterwards.

For patients comparing routes, the useful comparison is scope: which specialties, which records, what output, and what happens next. A lower fee for a narrower discussion is not automatically better value, and a broader review is not automatically necessary. The right scope is the one that answers your question.

A practical next step

Start with a short summary: the working diagnosis, your main question, what treatment you have already had, and which records exist. An initial enquiry is free and does not commit you to a proxy consultation or any paid service. If a multidisciplinary review looks relevant, we can explain the scope and fee for your case before anything is agreed. You can also read more about the rare-disease multidisciplinary review route if your question concerns a complex or undiagnosed condition.

The decision to proceed belongs to you, and the clinical conclusions belong to the treating clinicians. A good review leaves you with clearer questions and a realistic sense of what China care can and cannot offer at this stage.

Rare-disease MDT review

Sources & scope of this guide

References and official service information relevant to this guide.

  1. rare diseases
  2. Rare-disease MDT review

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.